DiscoverEmerging Tech HorizonsSynthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset
Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset

Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset

Update: 2025-09-10
Share

Description

Join guest host Dr. Liz Specht for a conversation with Matt Spence, the managing director and global head of venture capital banking at Barclays. In this episode Dr. Spence discusses the role food security plays in national security and how the government can incentivize and support biotechnology research and development. The episode explores how synthetic biology can be leveraged into additional defense uses and dispels common misconceptions about synthetic biology and national security.

To receive updates about the conference please join our mailing list here: https://www.emergingtechnologiesinstitute.org/sign-uphttp://emergingtechnologiesinstitute.orghttps://www.facebook.com/EmergingTechETIhttps://www.linkedin.com/company/ndia-eti-emerging-technologies-institutehttps://www.twitter.com/EmergingTechETI

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset

Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset

Dr. Arun Seraphin